Related Experiment Video
Updated: Jul 16, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Hypoxemia complicating LVAD insertion: novel application of the Amplatzer PFO occlusion device
Coimbatore V Srinivas1, Nicholas Collins, Michael A Borger
1Department of Anesthesia, Toronto General Hospital, Toronto, Ontario, Canada.
Insights
A patent foramen ovale (PFO) with a Chiari network caused severe hypoxemia during left ventricular assist device (LVAD) insertion. Percutaneous PFO closure and reduced LVAD flow successfully resolved the complication.
Area of Science:
- Cardiology
- Medical Devices
- Congenital Heart Defects
Background:
- Left ventricular assist devices (LVADs) are crucial for heart failure management.
- Interatrial shunting can complicate LVAD therapy, leading to paradoxical embolism and hypoxemia.
- Patent foramen ovale (PFO) and Chiari networks are known causes of right-to-left shunting.
Observation:
- A patient undergoing LVAD insertion developed profound systemic hypoxemia.
- The hypoxemia was attributed to right-to-left shunting through a PFO associated with a Chiari network.
- This shunt allowed deoxygenated blood to bypass the pulmonary circulation.
Findings:
- Successful management was achieved through percutaneous closure of the interatrial defect.
- An Amplatzer PFO occlusion device was used for the closure.
- Judicious reduction in LVAD flows also contributed to the patient's stabilization.
Implications:
- This case highlights the importance of screening for PFO in patients undergoing LVAD implantation.
- Percutaneous PFO closure is a viable strategy for managing hypoxemia caused by shunting during LVAD therapy.
- Understanding the interplay between cardiac devices and congenital anomalies is vital for patient outcomes.
Abstract:
We report a case of profound systemic hypoxemia complicating left ventricular assist device (LVAD) insertion due to right to left shunting through a patent foramen ovale (PFO) in association with a Chiari network. The patient was successfully managed with percutaneous closure of the interatrial defect using an Amplatzer PFO occlusion device and judicious reduction in LVAD flows.
Related Concept Videos
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
